DIM
BNGO icon

DLK Investment Management’s Bionano Genomics BNGO Stock Holding History

DLK Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-239
Closed -$4.14K – 88
2024
Q4 		$4.14K Buy
239
+33
+16% +$564 ﹤0.01% 89
2024
Q3 		$5.61K Hold
206
– – ﹤0.01% 111
2024
Q2 		$8.37K Hold
206
– – ﹤0.01% 103
2024
Q1 		$13.7K Buy
+206
New +$15.4K 0.01% 102

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

DLK Investment Management's BNGO Position: Q1 2025 in Review

DLK Investment Management sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 239 shares — an estimated $4.14K sold.

DLK Investment Management first reported a position in BNGO in Q1 2024 and held it in 4 quarters. The position peaked at $13.7K in Q1 2024. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • DLK Investment Management reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • DLK Investment Management sold 239 Bionano Genomics shares in Q1 2025, an estimated $4.14K.
  • DLK Investment Management first reported a position in Bionano Genomics in Q1 2024 and held it in 4 quarters.
  • DLK Investment Management's Bionano Genomics position peaked at $13.7K in Q1 2024.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on DLK Investment Management's 13F filing for Q1 2025, filed 23 Apr 2025.